Trials / Conditions / Gastroenteropancreatic Neuroendocrine Neoplasm
Gastroenteropancreatic Neuroendocrine Neoplasm
3 registered clinical trials studyying Gastroenteropancreatic Neuroendocrine Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Ne NCT05987176 | Imperial College London | Phase 2 |
| Withdrawn | Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cance NCT05582031 | Translational Research in Oncology | Phase 2 |
| Active Not Recruiting | NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Car NCT05262556 | Amr Mohamed MD | Phase 1 |